![[ Back to EurekAlert! ]](http://www.eurekalert.org/images/back2e.gif){kind=small}
|
Contact: Bill Schaller
william_schaller@dfci.harvard.edu
617-632-5357
Dana-Farber Cancer Institute
Caption: Peter Sicinski, M.D., Ph.D., and colleagues at Dana-Farber Cancer Institute have safely shut down breast cancer and a form of leukemia in mice by targeting abnormal proteins that control cells' growth cycles, and to which the cancers are "addicted."
Credit: Sam Ogden
Usage Restrictions: None
Related news release: Targeting cancers' 'addiction' to cell-cycle proteins shuts down tumors in mice
|